$26.69−0.27 (−1.00%)
At close: Nov 19, 2026, 4:00 PM ET· Nasdaq · USD
Surgery Partners (SGRY) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue compounds ~10.4%/yr (FY21→FY25), net margin −2.4%, and free cash flow (~$195.6M) tracks net income. Earnings are cash, not paper. Worth your attention in FY25: Share count (+75.6%). Visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▲6.2%
3,308.7
FY21→FY25CAGR +10.4%/yr
Net income ($M)▲53.7%
−77.9
one-off year: see footnoteCAGR —
Free cash flow ($M)▼6.7%
195.6
FY21→FY25CAGR +60.5%/yr
Diluted EPS▲54.1%
−0.61
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+75.6%
72.4mn → 127.2mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.
Capex
$78.7M
steady at 2.4% of revenue (−12.9% YoY).
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)
-2¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.
Margin trend · direction beats level Gross Operating Net
Over this window: gross 42.4% → 70.7%. Net margin -2.4% is below the sector median.
The receipt · income statement · FY21–FY25 USD thousands except per-share & ratios · hover a line for its definition
USD thousands except per-share & ratios
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 3,360,100.0 | 3,308,700.0 | 3,114,300.0 | 2,743,300.0 | 2,539,300.0 | 2,225,100.0 | ▲6.2% | +10.4% |
Cost of revenue | 578,900.0 | 971,000.0 | 1,922,100.0 | 1,714,100.0 | 1,456,100.0 | 1,280,700.0 | ▼49.5% | −6.7% |
Gross profit | 2,781,200.0 | 2,337,700.0 | 1,192,200.0 | 1,029,200.0 | 1,083,200.0 | 944,400.0 | ▲96.1% | +25.4% |
Selling, general & admin | 2,079,800.0 | 1,603,000.0 | 495,800.0 | 417,700.0 | 528,100.0 | 466,400.0 | ▲223.3% | +36.2% |
Total operating expenses | 2,417,500.0 | 1,948,200.0 | 843,400.0 | 701,200.0 | 738,000.0 | 642,200.0 | ▲131.0% | +32.0% |
Operating incomefeeds ROC rank | 363,700.0 | 389,500.0 | 348,800.0 | 328,000.0 | 345,200.0 | 302,200.0 | ▲11.7% | +6.5% |
Other income, net | −274,400.0 | −272,600.0 | −201,700.0 | −193,000.0 | −234,900.0 | −221,000.0 | — | — |
Pretax income | 89,300.0 | 116,900.0 | 147,100.0 | 135,000.0 | 110,300.0 | 81,200.0 | ▼20.5% | +9.5% |
Income tax | 18,600.0 | 18,000.0 | 134,600.0 | −300.0 | 23,300.0 | 10,500.0 | ▼86.6% | +14.4% |
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings | −87,000.0 | −77,900.0 | −168,100.0 | −11,900.0 | −54,600.0 | −70,900.0 | ▲53.7% | — |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | −0.67 | −0.61 | −1.33 | −0.09 | −0.59 | −1.12 | ▲54.1% | — |
Diluted shares (mn) | 128.87 | 127.21 | 126.12 | 125.61 | 91.95 | 72.43 | ▲0.9% | +15.1% |
| Margins | ||||||||
Gross margin77th pct in Healthcare | 82.8% | 70.7% | 38.3% | 37.5% | 42.7% | 42.4% | ▲32.4pp | +28.2pp |
Operating margin | 10.8% | 11.8% | 11.2% | 12.0% | 13.6% | 13.6% | ▲0.6pp | −1.8pp |
Net margin35th pct in Healthcare | −2.6% | −2.4% | −5.4% | −0.4% | −2.2% | −3.2% | ▲3.0pp | +0.8pp |
† TTM = trailing four quarters through 2026-09-30.FY23 effective tax rate was −0% vs a 15% norm for this window, likely a one-time item; see the filing.FY24 effective tax rate was 92% vs a 15% norm for this window, likely a one-time item; see the filing.
5 more years of statements and CSV export are on Premium, and 7 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-03-02 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Surgery Partners' revenue last fiscal year?
Surgery Partners reported revenue of $3,308.7M in fiscal 2025, up 6.2% from fiscal 2024.
What was Surgery Partners' net income?
Surgery Partners reported net income of −$77.9M in fiscal 2025, a net margin of −2.4%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

